Phibro Animal Health Corporation PAHC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 102.71M | 99.72M | 95.23M | 92.09M | 67.82M |
| Total Depreciation and Amortization | 50.74M | 49.99M | 49.16M | 49.33M | 48.01M |
| Total Amortization of Deferred Charges | 3.89M | 3.84M | 3.71M | 3.71M | 3.64M |
| Total Other Non-Cash Items | 12.74M | 10.50M | 17.62M | 12.41M | 14.40M |
| Change in Net Operating Assets | -84.35M | -95.10M | -99.59M | -64.45M | -57.06M |
| Cash from Operations | 85.73M | 68.95M | 66.13M | 93.08M | 76.80M |
| Capital Expenditure | -64.06M | -59.09M | -53.36M | -45.79M | -42.52M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 5.35M | 4.30M | -286.53M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.68M | -12.37M | -14.03M | -21.99M | 22.27M |
| Cash from Investing | -56.39M | -71.46M | -62.04M | -63.48M | -306.77M |
| Total Debt Issued | 368.41M | 305.41M | 281.53M | 289.53M | 708.53M |
| Total Debt Repaid | -376.90M | -291.94M | -274.78M | -312.71M | -436.41M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -19.47M | -19.46M | -19.46M | -19.46M | -19.45M |
| Other Financing Activities | -567.00K | -567.00K | 0.00 | 0.00 | 0.00 |
| Cash from Financing | -28.53M | -6.56M | -12.71M | -42.63M | 252.67M |
| Foreign Exchange rate Adjustments | 1.96M | 2.44M | 3.19M | 1.45M | -1.77M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.78M | -6.62M | -5.43M | -11.59M | 20.93M |